These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17024968)

  • 1. Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent.
    Ramakrishnan V; Bhaskar V; Law DA; Wong MH; DuBridge RB; Breinberg D; O'Hara C; Powers DB; Liu G; Grove J; Hevezi P; Cass KM; Watson S; Evangelista F; Powers RA; Finck B; Wills M; Caras I; Fang Y; McDonald D; Johnson D; Murray R; Jeffry U
    J Exp Ther Oncol; 2006; 5(4):273-86. PubMed ID: 17024968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.
    Bhaskar V; Zhang D; Fox M; Seto P; Wong MH; Wales PE; Powers D; Chao DT; Dubridge RB; Ramakrishnan V
    J Transl Med; 2007 Nov; 5():61. PubMed ID: 18042290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients.
    Ng CM; Bai S; Takimoto CH; Tang MT; Tolcher AW
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):207-17. PubMed ID: 19468731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits.
    Bhaskar V; Fox M; Breinberg D; Wong MH; Wales PE; Rhodes S; DuBridge RB; Ramakrishnan V
    Invest New Drugs; 2008 Feb; 26(1):7-12. PubMed ID: 17786386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody.
    Kuwada SK
    Curr Opin Mol Ther; 2007 Feb; 9(1):92-8. PubMed ID: 17330407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
    O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
    Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint Antiangiogenic Effect of ATN-161 and Anti-VEGF Antibody in a Rat Model of Early Wet Age-Related Macular Degeneration.
    Wang WQ; Wang FH; Qin WX; Liu HY; Lu B; Chung C; Zhu J; Gu Q; Shi W; Wen C; Wu F; Zhang K; Sun XD
    Mol Pharm; 2016 Sep; 13(9):2881-90. PubMed ID: 27089240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for age-related macular degeneration.
    Patel S
    Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volociximab in cancer.
    Almokadem S; Belani CP
    Expert Opin Biol Ther; 2012 Feb; 12(2):251-7. PubMed ID: 22192080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel integrin alpha5beta1 antagonistic peptide, A5-1, screened by Protein Chip system as a potent angiogenesis inhibitor.
    Kim EY; Bang JY; Chang SI; Kang IC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1288-93. PubMed ID: 18996355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
    Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
    Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single and combined effects of alphavbeta3- and alpha5beta1-integrins on capillary tube formation in a human fibrinous matrix.
    Laurens N; Engelse MA; Jungerius C; Löwik CW; van Hinsbergh VW; Koolwijk P
    Angiogenesis; 2009; 12(3):275-85. PubMed ID: 19449108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.
    Xiao D; Singh SV
    Cancer Res; 2007 Mar; 67(5):2239-46. PubMed ID: 17332354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of highly active and selective ligands for the alpha5beta1 integrin receptor.
    Heckmann D; Meyer A; Laufer B; Zahn G; Stragies R; Kessler H
    Chembiochem; 2008 Jun; 9(9):1397-407. PubMed ID: 18481343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
    Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M; Truax R; Stout R; Portier R; Losso JN
    J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.